Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy - Wu, Jianping; Wei, Xiaona; Li, Jiajia; Gan, Yangang; Zhang, Rui; Han, Qianqian; Liang, Peifen; Zeng, Yuchun; Yang, Qiongqiong (Frontiers in Immunology, 2022)